Tracking baby health when moms take MS drug
NCT ID NCT06433765
Summary
This study follows pregnant women with multiple sclerosis to understand if the medication BRIUMVI affects their babies' health. Researchers will compare birth outcomes between women who take BRIUMVI during pregnancy and those who don't. The main goal is to check if babies have more birth defects when their mothers take this medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BRIUMVI® Pregnancy Registry Virtual Research Coordination Center
RECRUITINGWilmington, North Carolina, 28401-3331, United States
Conditions
Explore the condition pages connected to this study.